QUÉBEC CITY, Aug. 2, 2011
/PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ)
(the "Company") today announced that its Senior Vice President and
Chief Medical Officer, Paul Blake,
MD, will make a corporate presentation at the upcoming Canaccord
Genuity 30th Annual Growth Conference on Tuesday, August 9, 2011, at 2 p.m. (Eastern Time) in the London Room of the
Intercontinental Boston Hotel, in Boston.
A live webcast of the presentation will be available on Aeterna
Zentaris' website at www.aezsinc.com, in the Newsroom section. A
replay of the webcast will also be available on the Company's
website for a period of 90 days.
About Aeterna Zentaris Inc.
Aeterna Zentaris is a late-stage oncology drug development
company currently investigating potential treatments for various
cancers including colorectal, multiple myeloma, endometrial,
ovarian, prostate and bladder cancer. The Company's innovative
approach of "personalized medicine" means tailoring treatments to a
patient's specific condition and to unmet medical needs. Aeterna
Zentaris' deep pipeline is drawn from its proprietary discovery
unit providing the Company with constant and long-term access to
state-of-the-art therapeutic options. For more information please
visit www.aezsinc.com.
SOURCE AETERNA ZENTARIS INC.